Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jun 21:5:18.
doi: 10.1186/s12348-015-0048-x. eCollection 2015.

Treatment of Acanthamoeba neurotrophic corneal ulcer with topical matrix therapy

Antonio Mateo  1 , Beatriz Abadía  2 , Pilar Calvo  1 , Enrique Minguez  3 , Luis Pablo  1 , José Manuel Benitez Del Castillo  4
Affiliations

Treatment of Acanthamoeba neurotrophic corneal ulcer with topical matrix therapy

Antonio Mateo et al. J Ophthalmic Inflamm Infect. .

Abstract

Background: This study was done to evaluate the visual and anatomical outcomes of topical regenerating agents as a novel therapy for neutrophic corneal ulcer (NCU) secondary to acanthamoeba infection.

Findings: A 20-year-old woman with a history of contact lens wear was referred to our hospital for keratitis after responding poorly to conventional treatment. In vivo confocal microscopy images suggested acanthamoeba keratitis with double-walled cysts in the anterior corneal stroma. Acanthamoeba infection was confirmed by laboratory findings. She was started on 0.1 % propamidine and 0.02 % chlorhexidine drops every hour. The antibiotic and antifungal drops were stopped when bacterial and fungal cultures proved negative. A central neurotrophic corneal ulcers (NCU) appeared, and despite treatment with artificial tears, bandage contact lens, and autologous serum, the ulcer worsened and she was treated with topical CACICOL20 (1 drop every 2 days) for 8 weeks. The corneal defect was completely repaired in 3 weeks. The treatment was well tolerated, and no local or systemic side effects were noted. Visual acuity remained 20/400. Two months later, the defect was still closed and the patient continued with 0.1 % propamidine and 0.02 % chlorhexidine drops, bandage contact lens, artificial tears, and autologous serum.

Conclusions: Topical regenerating agents interact with components of the extracellular matrix, binding matrix proteins and protecting them from proteolysis, restoring the matrix environment, and improving tissue healing. In this case, CALCICOL20 was effective for vision stabilization, wound healing, and was well tolerated for NCU secondary to acanthamoeba infection.

Keywords: Acanthamoeba; Corneal neurotrophic ulcer; RGTA.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Corneal neurotrophic ulcer secondary to acanthamoeba keratitis
Fig. 2
Fig. 2
Corneal neurotrophic ulcer worsening despite intensive treatment
Fig. 3
Fig. 3
Complete corneal healing after CACICOL20 treatment
See this image and copyright information in PMC

References

    1. Sacchetti M, Lambiase A. Diagnosis and management of neurotrophic keratitis. Clin Ophthalmol. 2014;8:571–579. - PMC - PubMed
    1. Graffi S, Peretz A, Jabaly H, Naftali M. Acanthamoeba keratitis. Isr Med Assoc J. 2013;15(4):182–5. - PubMed
    1. Barbier-Chassefière V, Garcia-Filipe S, Yue XL, et al. Matrix therapy in regenerative medicine, a new approach to chronic wound healing. J Biomed Mater Res A. 2009;90(3):641–7. doi: 10.1002/jbm.a.32124. - DOI - PubMed
    1. Chebbi CK, Kichenin K, Amar N, et al. Pilot study of a new matrix therapy agent (RGTA OTR4120) in treatment-resistant corneal ulcers and corneal dystrophy. J Fr Ophtalmol. 2008;31(5):465–71. doi: 10.1016/S0181-5512(08)72462-8. - DOI - PubMed
    1. De Monchy I, Labbé A, Pogorzalek N, et al. Management of herpes zoster neurotrophic ulcer using a new matrix therapy agent (RGTA): a case report. J Fr Ophtalmol. 2012;35(3):187.e1-6. doi: 10.1016/j.jfo.2011.09.002. - DOI - PubMed

LinkOut - more resources